Myopericarditis After COVID-19 Booster Dose Vaccination
- PMID: 35351285
- PMCID: PMC8957365
- DOI: 10.1016/j.amjcard.2022.02.039
Myopericarditis After COVID-19 Booster Dose Vaccination
References
-
- Sharff KA, Dancoes DM, Longueil JL, Johnson ES, Lewis PF. Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: a comparison of completeness and timeliness of two methods. Preprint. medRxiv. Available at: 10.1101/2021.12.21.21268209. Accessed on 2/14/2022. - DOI - PMC - PubMed
-
- Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, Broder KR, Gee J, Weintraub E, Shimabukuro T, Scobie HM, Moulia D, Markowitz LE, Wharton M, McNally VV, Romero JR, Talbot HK, Lee GM, Daley MF, Oliver SE. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices — United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(27):977–982. - PMC - PubMed
-
- Centers for Disease Control and Prevention. ACIP presentation slides: November 19, 2021 meeting. Available at: https://www.cdc.gov/vaccines/acip/meetings/slides-2021-11-19.html. Accessed on 2/14/2022.
-
- Centers for Disease Control and Prevention. ACIP presentation slides: January 5, 2022 meeting. Available at: https://www.cdc.gov/vaccines/acip/meetings/slides-2022-01-05.html. Accessed on 2/14/2022.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical